Alethia Young's most recent trade in Bicycle Therapeutics Plc - ADR was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 50,000 | 94,704 | - | 0 | Ordinary Shares | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 4,000 | 21,067 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,475 | 3,475 | - | - | Stock Option (Right to Buy) | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.80 per share. | 02 Jan 2026 | 3,289 | 91,415 | - | 6.8 | 22,365 | Ordinary Shares |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 02 Jan 2026 | 2,456 | 88,959 | - | 6.4 | 15,841 | Ordinary Shares |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 02 Jan 2026 | 1,878 | 87,081 | - | 6.5 | 12,282 | Ordinary Shares |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.60 per share. | 02 Oct 2025 | 265 | 44,704 | - | 8.6 | 2,280 | Ordinary Shares |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 02 Oct 2025 | 217 | 44,969 | - | 8.4 | 1,823 | Ordinary Shares |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 02 Jul 2025 | 204 | 45,186 | - | 7.1 | 1,446 | Ordinary Shares |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 11,393 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.02 per share. | 02 Apr 2025 | 215 | 45,390 | - | 8.0 | 1,724 | Ordinary Shares |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 17,067 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 87,000 | 87,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 47,000 | - | 0 | Ordinary Shares | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 02 Jan 2025 | 1,395 | 45,605 | - | 14.1 | 19,656 | Ordinary Shares |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 5,230 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Young Alethia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Young Alethia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 13,067 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,000 | 24,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics PLC (ADR) | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 12,000 | 12,000 | - | 0 | Ordinary Shares | |
| Graphite Bio Inc | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option (right to buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 9,067 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 3,200 | 3,200 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 1,867 | 5,067 (0%) | 0% | 0 | Common Stock | |
| Graphite Bio Inc | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 350,000 | 350,000 | - | - | Stock Option (right to buy) |